I am quite sure that if I see an angle of 5 to 10 years, regardless of what happens in the international market, the Indian markets are going to perform well. May be if the ... Now Indian pharma companies had two challenges – one FDA problems that is more like a manufacturing problem, second is pricing.
Read more: In a 5 or 10-year horizon, I am as bullish as ever: Rakesh Jhunjhunwala